Concepedia

Publication | Open Access

Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS)

63

Citations

31

References

2014

Year

Abstract

Delayed-release DMF improved clinical and neuroradiological outcomes relative to placebo in newly diagnosed RRMS patients.

References

YearCitations

Page 1